Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 15, 2016
Politics, Policy & Law

Nature won't wait

Fast start for Zika virus vaccines
BioCentury | Aug 6, 2012
Clinical News

ChimeriVax: Phase II data

BioCentury | Feb 14, 2011
Clinical News

Imojev regulatory update

BioCentury | Mar 22, 2010
Clinical News

Vaxine preclinical data

BioCentury | Jul 13, 2009
Clinical News

Imojev regulatory update

BioCentury | Apr 27, 2009
Clinical News

Tetravalent dengue vaccine: Phase IIb started

BioCentury | Apr 27, 2009
Clinical News

Tetravalent dengue vaccine: Phase IIb started

BioCentury | Feb 23, 2009
Clinical News

ChimeriVax-Dengue: Phase IIb started

BioCentury | Dec 8, 2008
Regulation

Tropical diseases pipeline

Items per page:
1 - 10 of 76